Researcher/postdoc position in CAR T cells and antibody drug conjugates
- Institute for Cancer Research, Department of Cancer Immunology- (in new tab)
- About the position
Research Description: The Kyte Group has developed several tumor-targeting chimeric antigen receptors (CARs) and other constructs for T cell therapy, as well as tumor targeting antibodies. The successful applicant will work on a new project called “CAR360”, for development of personalized T cell therapy countering tumor escape in treatment refractory solid cancers. This includes approaches countering immune suppression and the targeting of multiple antigens and tumor subpopulations. The project will make use of proprietary constructs developed in the group. The successful applicant will also work on the development of therapy with bispecific antibodies, nanobodies and antibody-drug conjugates (ADC) targeting tumor-specific antigens. The required methods have been established.Key information
- Application ...